Die hiesigen Medtech-Unternehmen, die Uhrenindustrie und andere Hersteller exportieren viel in die USA. Allfällige Zölle könnten deshalb die Solothurner Wirtschaft überdurchschnittlich treffen – stärk ...

Biogen zum Beispiel soll laut «NZZ» eine ... Gegründet wurde die GZA vor über 25 Jahren. Der Kanton Solothurn ist seit 2002 ununterbrochen dabei. Der von der GZA propagierte ...

Derweil will der Kanton Solothurn, seit 2002 mit dabei ... der Greater Zurich Area wird die Ansiedlung des US-Pharmakonzerns Biogen in Luterbach SO vor neun Jahren verbucht.

Biogen (BIIB) and Eisai announced an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as treatment for early AD, or mild cognitive impairment due to ...

Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALF) are expected to face another delay in launching their new Alzheimer's drug, lecanemab, in the EU after the European Commission on Friday asked the ...

In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other healthcare stocks. McKinsey reported that, since 2019, the US healthcare industry ...

In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other S&P 500 stocks. 2024 was a memorable year for the broad market index, which posted a gain ...

European Union regulators will review new information relating to the safety of Eisai Co.’s and Biogen Inc.’s medicine for Alzheimer’s disease, providing a response after a meeting next month.

SAN FRANCISCO (Reuters) - Biogen expects revenue from new launches to exceed its current sales by 2028 and does not feel the need to chase additional business development deals, the company's CEO ...

Investors in Biogen Inc (Symbol: BIIB) saw new options become available today, for the March 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB ...